INSIGHTS
Articles, conference updates, market insight and interviews from the Biopharma, Pharma and Healthcare communities we convene.
4 pieces shown
- BiopharmaMarket insight
Why Singapore Is Emerging as Biopharma’s China+1 Hub
Singapore’s biopharmaceutical sector is navigating short-term production volatility while strengthening its long-term position as a trusted bridge between China and Western markets. This article examines how Singapore’s regulatory credibility, advanced manufacturing ecosystem and geopolitical neutrality support its emerging role as a China+1 hub for global biopharma.
Read more: Why Singapore Is Emerging as Biopharma’s China+1 Hub - BiopharmaMarket insight
APAC’s Radiopharmaceutical Landscape Is Taking Shape: Where Are the Next Hubs Emerging?
Asia-Pacific’s radiopharmaceutical sector is expanding as countries invest in isotope production, drug development, specialised manufacturing and theranostics infrastructure. This article examines how Australia, China, Japan, South Korea, India, Singapore and Southeast Asia are developing distinct roles within an increasingly interconnected regional ecosystem.
Read more: APAC’s Radiopharmaceutical Landscape Is Taking Shape: Where Are the Next Hubs Emerging? - HealthcareMarket insight
Indonesia’s Healthcare Transformation Is Accelerating
Indonesia’s healthcare sector is entering a significant period of transformation as investment, technology adoption and international cooperation reshape the market. This article examines how developments across primary healthcare infrastructure, biopharma, digital health and regulation are creating a more connected and resilient healthcare ecosystem.
Read more: Indonesia’s Healthcare Transformation Is Accelerating - BiopharmaMarket insight
Asia’s Biopharma Manufacturing Landscape Is Changing. Where Are the New Hubs Emerging?
Asia’s biopharmaceutical manufacturing landscape is evolving into a network of specialised ecosystems rather than a single regional hub. This article examines how South Korea, Singapore, China, India, Japan and emerging Southeast Asian markets are developing distinct roles across biologics, advanced therapies and vaccine production.
Read more: Asia’s Biopharma Manufacturing Landscape Is Changing. Where Are the New Hubs Emerging?
